Synopsis
Synopsis
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4' Epi Adriamycin
2. 4' Epi Doxorubicin
3. 4' Epi Dxr
4. 4' Epiadriamycin
5. 4' Epidoxorubicin
6. 4'-epi-adriamycin
7. 4'-epi-doxorubicin
8. 4'-epi-dxr
9. 4'-epiadriamycin
10. 4'-epidoxorubicin
11. Ellence
12. Epi Cell
13. Epi-cell
14. Epicell
15. Epilem
16. Epirubicin
17. Farmorubicin
18. Farmorubicina
19. Farmorubicine
20. Hydrochloride, Epirubicin
21. Imi 28
22. Imi-28
23. Imi28
24. Nsc 256942
25. Nsc-256942
26. Nsc256942
27. Pharmorubicin
1. Pharmorubicin
2. 56390-09-1
3. Ellence
4. Epirubicin Hcl
5. Farmorubicin
6. Farmorubicina
7. Imi-28
8. 4'-epidoxorubicin Hydrochloride
9. Epirubicin Ebewe
10. Epirubicin (hydrochloride)
11. Nsc-759195
12. Mls001401404
13. Nsc 256942
14. Pidorubicin
15. Wp-697
16. 22966tx7j5
17. 4'-epi-adriamycin Hydrochloride
18. Smr000466308
19. 56390-09-1 (hcl)
20. (8s,10s)-10-(((2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride
21. Epirubitec
22. 4'-epi-adriamycin
23. Epidoxorubicin Hydrochloride
24. (7s,9s)-7-[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride
25. Ccris 4477
26. Einecs 260-145-2
27. Unii-22966tx7j5
28. Ellence (tn)
29. 4'-epi-doxorubicin
30. Epirubicin Hydrochlorid
31. 4'-epidoxorubicin Hcl
32. Cpd000466308
33. Epirubicin Hydrochloride [usan:usp:jan]
34. E-adm
35. 4'-epi-dx
36. Schembl3165
37. (1s,3s)-3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranoside Hydrochloride
38. Mls000759412
39. 4-epidoxorubicin Hydrochloride
40. Epirubicin Hcl [vandf]
41. Chembl1200981
42. Dtxsid50860297
43. Pharmakon1600-01505708
44. Amy10308
45. Ex-a2654
46. Epirubicin Hcl (4'-epidoxorubicin)
47. Epirubicin Hydrochloride [mi]
48. Hy-13624a
49. Mfcd00941448
50. Nsc759195
51. S1223
52. Epirubicin Hydrochloride (jp17/usp)
53. Epirubicin Hydrochloride [jan]
54. Bcp9000651
55. Ccg-100950
56. Cs-1773
57. Epirubicin Hydrochloride [usan]
58. Nc00200
59. Epirubicin Hydrochloride [mart.]
60. Epirubicin Hydrochloride [usp-rs]
61. Epirubicin Hydrochloride [who-dd]
62. (8s-cis)-10-((3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione Hydrochloride
63. 5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, Hydrochloride, (8s-cis)-
64. 5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-arabinohexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, Hydrochloride, (8s,10s)-
65. As-75323
66. Epirubicin Hydrochloride, >=90% (hplc)
67. E0840
68. Epirubicin Hydrochloride [orange Book]
69. D02214
70. D83113
71. Epirubicin Hydrochloride [ep Monograph]
72. Epirubicin Hydrochloride [usp Monograph]
73. Sr-01000763557
74. Q-101406
75. Sr-01000763557-3
76. Q27253634
77. Epirubicin Hydrochloride, British Pharmacopoeia (bp) Reference Standard
78. Epirubicin Hydrochloride, European Pharmacopoeia (ep) Reference Standard
79. Epirubicin Hydrochloride, United States Pharmacopeia (usp) Reference Standard
80. (1s,3s)-3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-.alpha.-l-arabino-hexopyranoside Hydrochloride
81. (8s,10s)-10-(((2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dionehydrochloride
82. (8s,10s)-10-((2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride
83. (8s,10s)-10-{[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione Hydrochloride
84. 5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-.alpha.-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, Hydrochloride, (8s-cis)-
85. 5,12-naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, Hydrochloride (1:1), (8s,10s)-
Molecular Weight | 580.0 g/mol |
---|---|
Molecular Formula | C27H30ClNO11 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 5 |
Exact Mass | 579.1507385 g/mol |
Monoisotopic Mass | 579.1507385 g/mol |
Topological Polar Surface Area | 206 Ų |
Heavy Atom Count | 40 |
Formal Charge | 0 |
Complexity | 977 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Ellence |
Drug Label | ELLENCE Injection (epirubicin hydrochloride injection) is an anthracycline cytotoxic agent, intended for intravenous administration. ELLENCE is supplied as a sterile, clear, red solution and is available in polypropylene vials containing 50 and 200 m... |
Active Ingredient | Epirubicin hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 200mg/100ml (2mg/ml); 50mg/25ml (2mg/ml) |
Market Status | Prescription |
Company | Pfizer |
2 of 4 | |
---|---|
Drug Name | Epirubicin hydrochloride |
Drug Label | Epirubicin hydrochloride injection is an anthracycline cytotoxic agent, intended for intravenous administration. Epirubicin hydrochloride injection is supplied as a sterile, clear, red solution and is available invials containing 50 mg and 200 mg o... |
Active Ingredient | Epirubicin hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 200mg/100ml (2mg/ml); 50mg/25ml (2mg/ml); 150mg/75ml (2mg/ml); 10mg/5ml (2mg/ml) |
Market Status | Prescription |
Company | Actavis Elizabeth; Fresenius Kabi Usa; Hospira; Fresenius Kabi Oncol; Ebewe Pharma; Onco Therapies; Teva Pharms Usa; Eurohlth Intl; Cipla; Hisun Pharm Hangzhou; Akorn |
3 of 4 | |
---|---|
Drug Name | Ellence |
Drug Label | ELLENCE Injection (epirubicin hydrochloride injection) is an anthracycline cytotoxic agent, intended for intravenous administration. ELLENCE is supplied as a sterile, clear, red solution and is available in polypropylene vials containing 50 and 200 m... |
Active Ingredient | Epirubicin hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 200mg/100ml (2mg/ml); 50mg/25ml (2mg/ml) |
Market Status | Prescription |
Company | Pfizer |
4 of 4 | |
---|---|
Drug Name | Epirubicin hydrochloride |
Drug Label | Epirubicin hydrochloride injection is an anthracycline cytotoxic agent, intended for intravenous administration. Epirubicin hydrochloride injection is supplied as a sterile, clear, red solution and is available invials containing 50 mg and 200 mg o... |
Active Ingredient | Epirubicin hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 200mg/100ml (2mg/ml); 50mg/25ml (2mg/ml); 150mg/75ml (2mg/ml); 10mg/5ml (2mg/ml) |
Market Status | Prescription |
Company | Actavis Elizabeth; Fresenius Kabi Usa; Hospira; Fresenius Kabi Oncol; Ebewe Pharma; Onco Therapies; Teva Pharms Usa; Eurohlth Intl; Cipla; Hisun Pharm Hangzhou; Akorn |
Antibiotics, Antineoplastic
Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)
Topoisomerase II Inhibitors
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?